Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: A randomized trial

Additional Metadata
Persistent URL	doi.org/10.1001/jama.293.17.2109, hdl.handle.net/1765/58931
Journal	J A M A: The Journal of the American Medical Association
Organisation	Department of Cardiology
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Valgimigli, M., Percoco, G., Malagutti, P., Campo, G., Ferrari, F., Barbieri, D., Cicchitelli, G., McFadden, E., Merlini, F., Ansani, L., Guardigli, G., Bettini, A., Parrinello, P., Boersma, E.& Ferrari, R. (2005). Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: A randomized trial. J A M A: The Journal of the American Medical Association, 293(17), 2109–2117.https://doi.org/10.1001/jama.293.17.2109

Publication